AFP and hepatocellular carcinoma: A meta-analysis including seven studies confirmed that plasma SPP1 elevation and AFP-based results have comparable diagnostic performance [68,69], although elevated SPP1 may be linked to other malignancies, therefore should be combined with other HCC-specific biomarkers [70].